Introduction

The World Health Organization has announced a partnership with Singapore government-owned investment firm Temasek Holdings to develop what it describes as 'interoperable digital health wallets' for global use. The initiative builds on digital documentation systems used during the COVID-19 pandemic and follows recent amendments to the WHO’s International Health Regulations.

The partnership, announced earlier this week, will begin with a pilot program involving the 11 member states of the Association of Southeast Asian Nations (ASEAN). According to the WHO, the program aims to create a 'replicable model' for potential export to other countries. The digital wallets will initially contain digital international certificates of vaccination or prophylaxis, with plans to later expand to 'broader personal health summaries' ^[1][2][3].

WHO Announces Partnership for Global Digital Health Passports

The WHO stated the initiative 'builds on lessons from the COVID-19 pandemic, which demonstrated the urgency of reliable, verifiable digital health documentation' ^[2]. Kee Kirk Chuen, Temasek’s head of Health & Well-being, said the COVID-19 pandemic 'showed how important it is for health records to be trusted, verifiable and able to travel with people across borders' ^[2].

The pilot program in Southeast Asia is intended to serve as a test case for broader implementation. According to the WHO announcement, the system will use standards developed by the WHO Global Digital Health Certification Network (GDHCN), which was launched in partnership with the European Commission in 2023 ^[2]. The partnership follows 2024 amendments to the International Health Regulations (IHR) which recommended the development of 'globally recognized digital health certificates' ^[2].

Temasek's Pharmaceutical and Digital Health Investments

Temasek Holdings, owned by the Government of Singapore, has a substantial investment portfolio in pharmaceutical companies and digital health infrastructure. In June 2020, Temasek participated in a $250 million investment in BioNTech, a German biotechnology company, just months before BioNTech released a COVID-19 vaccine in conjunction with Pfizer ^[2][3]. A BioNTech press release at the time stated the investment would boost the company’s efforts to develop 'patient-specific immunotherapies for the treatment of cancer and infectious diseases' ^[2].

According to a 2021 Asia Business Council report, Temasek’s investment in BioNTech 'is just one example of how the government-owned but private-sector-oriented company went full out as an investor and a steward to fight the coronavirus' ^[2]. The firm’s portfolio includes extensive investments in pharmaceutical and digital health providers. In 2021, Temasek helped lead a $700 million investment round for Chinese pharmaceutical company Abogen Biosciences to advance its mRNA COVID-19 vaccine candidate to late-phase trials ^[2].

Temasek also has a history of developing digital health verification technology. In 2021, its digital identity subsidiary Affinidi developed and piloted Unifier, a universal verification system for authenticating COVID-19 vaccination and test results across different QR code standards ^[2]. The firm has additional investments in Clover Biopharmaceuticals, Celltrion Inc., and Novotech, a clinical research organization specializing in drug and vaccine trials ^[2].

Connections to Gates Foundation and Global Health Initiatives

Temasek maintains collaborative ties with the Bill & Melinda Gates Foundation and Gates-linked global health initiatives. Bloomberg reported that the Philanthropy Asia Alliance -- Temasek’s charitable arm -- lists the Gates Foundation as one of its early core members ^[2]. In 2022, Temasek invested in Select, a fund launched under Breakthrough Energy Ventures, a climate-focused investor founded by Bill Gates ^[2]. Yahoo! Finance reported at the time that Temasek was 'already an existing co-investor to several other Gates-backed ventures' ^[2].

In 2024, the Gates Foundation opened a Singapore office, an announcement made at the Philanthropy Asia Summit organized by Temasek Trust’s Philanthropy Asia Alliance ^[2]. Temasek has also partnered directly with Gavi, the Vaccine Alliance, on vaccination programs in Southeast Asia. According to a 2025 Gavi press release, Temasek partnered with the Clinton Health Access Initiative and the UBS Optimus Foundation on a $4.5 million initiative 'to reach zero-dose and under-immunized children' in Indonesia ^[2]. The Gates Foundation funded Gavi’s launch in 1999 and holds a permanent seat on its board. Gavi is listed by the WHO as an official stakeholder ^[2].

Concerns About Conflicts of Interest and Program Durability

Public health physician Dr. David Bell, a senior scholar at the Brownstone Institute, said the WHO is required to concentrate on vaccine passports because they are 'important from an investment viewpoint to its major funders, who fund the WHO through voluntary specified funding -- meaning the WHO is required to follow the directions of the funder' ^[2]. Bell said major WHO funders, including the Gates Foundation, 'have direct financial interests in increasing the use of both vaccines and digital platforms' ^[2].

Natalie Winters, co-host of 'Bannon’s War Room,' argued that systems justified as temporary during the pandemic are being formalized into broader, more durable infrastructure. 'During COVID, digital health verification systems determined whether people could travel, work, or enter public spaces based off vaccination status,' Winters wrote on Substack. 'Those systems were justified as temporary. Now they are being formalized into something much broader and far more durable' ^[2].

Bell also addressed Temasek’s direct involvement. 'While it is reasonable for an investment firm like Temasek to invest in pharmaceutical companies, it obviously should exclude them from participating with WHO in activities that directly improve their subsequent return on investment,' Bell said. 'This is a really basic conflict of interest that would be a no-go for any ethical public health program, as their duty as an investment house is to maximize return on investment from the companies they have invested in' ^[2].

Implementation Through WHO Regulatory Framework

The partnership leverages a regulatory framework established by recent amendments to the WHO’s International Health Regulations. The 2024 amendments, which took effect in September 2025, included a recommendation for the development of digital health certificates ^[2]. The WHO cited these amendments when announcing its collaboration with Temasek ^[2].

Independent journalist James Roguski said he warned two years ago that the WHO’s efforts to pass the IHR amendments would lead to a push for global health passes. 'Nations may be somewhat constrained in their abuse of their own citizens by their constitutions, charters of rights, or laws,' Roguski said. 'But numerous articles within the IHR clearly state that sovereign nations are absolutely free to disregard and abuse the rights, freedoms and health of travelers who may be visiting from other countries' ^[2].

Tim Hinchliffe, editor of The Sociable, argued that for Gates and other unelected globalists, globally interoperable vaccine passports serve a couple of purposes. 'First off, there’s a lot of money in getting everyone in the world to get injected with their products. It’s a great return on investment. Secondly, vaccine passports further the agenda to get everybody in the world pegged to a digital identity scheme,' Hinchliffe said. He cited a 2022 World Economic Forum report acknowledging that vaccine passports are a type of digital identity ^[2].

Conclusion

The WHO-Temasek partnership marks a significant step toward institutionalizing digital health documentation on a global scale. The initiative, framed as a response to pandemic-era lessons, is being implemented through a network of financial and political alliances involving major pharmaceutical investors and global health foundations.

Critics of the plan warn that it represents the transformation of emergency measures into permanent infrastructure, with inherent conflicts of interest and profound implications for personal privacy and autonomy. As the pilot program launches in Southeast Asia, observers note its design is intended for global replication, setting the stage for a worldwide system of digital health surveillance linked to international travel and access to services.

References

1. The World Health Organization is partnering with Temasek to develop interoperable digital health wallets, beginning with digital vaccination ... - Instagram.
2. WHO Teams With Singapore Firm Tied to Pfizer, Bill Gates to Roll Out Global Vaccine Passports - The Defender. Michael Nevradakis. March 27, 2026.
3. WHO Teams With Singapore Firm Tied to Pfizer, Bill Gates to Roll Out Global Vaccine Passports - Substack.
4. Urgent Warning Vaccine Passports Linked to Y - Mercola.com.
5. Bill Gates Pushes Digital ID for Newborns in Kenya as Critics Warn of Surveillance Risk - Children's Health Defense. Michael Nevradakis.
6. UN Launches Gates-Funded Global Digital ID Program as Experts Warn of 'Totalitarian Nightmare' - Children's Health Defense.
7. Trends-Journal-2022-12-37.
8. Trends-Journal-2021-05-15.
9. Brighteon Broadcast News.
10. Mike Adams interview with Catherine Austin Fitts - July 21 2025.
11. Mike Adams interview with Ed Dowd - April 7 2023.
12. Mike Adams interview with Marjory Wildcraft - April 17 2025.